1st Department of Medicine, Cologne University Hospital
1st Department of Medicine, Cologne University Hospital
Cologne, Germany4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2025-04-06 | NCT06045195 | |
| Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy | classic Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2025-04-03 | NCT03480334 | |
| Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma | classic Hodgkin lymphoma | Recruiting | Phase 2 | 2024-08-23 | NCT04838652 | |
| Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma | classic Hodgkin lymphoma | Recruiting | Phase 2 | 2024-07-26 | NCT04837859 |